Presentation TCT 2013 Ranolazine, Bendavia, and Other Unique Pharmacologic Agents Presenter: Robert Kloner October 31, 2013 REGISTER for free or LOG IN to view this content ACS/AMI Presentation TCT 2013 Up Next Presentation TCT 2013 TCT-108. Baseline Mitral Regurgitation Does Not Affect 30 Day to Two Year Mortality after Transcatheter Aortic-Valve Implantation (TAVI). A Report on 576 Patients from the Swedi... Presenter: Andreas R?ck October 29, 2013 More slides + Presentation TCT 2013 A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary... Presenter: William O'Neill October 31, 2013 Presentation TCT 2013 Thoughtful Insights(6) Presenter: James Hermiller Jr November 01, 2013 We Recommend
Presentation TCT 2013 TCT-108. Baseline Mitral Regurgitation Does Not Affect 30 Day to Two Year Mortality after Transcatheter Aortic-Valve Implantation (TAVI). A Report on 576 Patients from the Swedi... Presenter: Andreas R?ck October 29, 2013
Presentation TCT 2013 A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary... Presenter: William O'Neill October 31, 2013